Literature DB >> 16854069

3'-Substituted 7-halogenoindirubins, a new class of cell death inducing agents.

Yoan Ferandin1, Karima Bettayeb, Marina Kritsanida, Olivier Lozach, Panagiotis Polychronopoulos, Prokopios Magiatis, Alexios-Leandros Skaltsounis, Laurent Meijer.   

Abstract

Indirubins are kinase inhibitory bis-indoles that can be generated from various plant, mollusk, mammalian, and bacterial sources or chemically synthesized. We here report on the synthesis and biological evaluation of 3'-substituted 7-halogenoindirubins. Molecular modeling and kinase assays suggest that steric hindrance prevents 3'-substituted 7-halogenoindirubins from interacting with classical kinase targets of other indirubins such as cyclin-dependent kinases and glycogen synthase kinase-3. Surprisingly 3'-substituted 7-halogenoindirubins induce cell death in a diversity of human tumor cell lines. Although some 3'-substituted 7-halogenoindirubins appear to induce effector caspase-independent, nonapoptotic cell death, others trigger the landmarks of classical apoptosis. A structure-activity relationship study was performed to optimize 3'-substituted 7-halogenoindirubins with respect to solubility and cell death induction. Despite their unidentified targets, 3'-substituted 7-halogenoindirubins constitute a new promising family of antitumor agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16854069     DOI: 10.1021/jm060314i

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  19 in total

1.  Isatin derivatives with activity against apoptosis-resistant cancer cells.

Authors:  Nikolai M Evdokimov; Igor V Magedov; Dominic McBrayer; Alexander Kornienko
Journal:  Bioorg Med Chem Lett       Date:  2016-02-08       Impact factor: 2.823

2.  From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity.

Authors:  Emilie Durieu; Eric Prina; Olivier Leclercq; Nassima Oumata; Nicolas Gaboriaud-Kolar; Konstantina Vougogiannopoulou; Nathalie Aulner; Audrey Defontaine; Joo Hwan No; Sandrine Ruchaud; Alexios-Leandros Skaltsounis; Hervé Galons; Gerald F Späth; Laurent Meijer; Najma Rachidi
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

3.  6-Bromoindirubin-3'-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells.

Authors:  Lucy Liu; Sangkil Nam; Yan Tian; Fan Yang; Jun Wu; Yan Wang; Anna Scuto; Panos Polychronopoulos; Prokopios Magiatis; Leandros Skaltsounis; Richard Jove
Journal:  Cancer Res       Date:  2011-05-24       Impact factor: 12.701

4.  Indirubin Analogues Inhibit Trypanosoma brucei Glycogen Synthase Kinase 3 Short and T. brucei Growth.

Authors:  Antonia Efstathiou; Nicolas Gaboriaud-Kolar; Vassilios Myrianthopoulos; Konstantina Vougogiannopoulou; Ines Subota; Stephanie Aicher; Emmanuel Mikros; Philippe Bastin; Alexios-Leandros Skaltsounis; Ketty Soteriadou; Despina Smirlis
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

5.  Soluble 3',6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase -3 alter circadian period.

Authors:  Konstantina Vougogiannopoulou; Yoan Ferandin; Karima Bettayeb; Vassilios Myrianthopoulos; Olivier Lozach; Yunzhen Fan; Carl Hirschie Johnson; Prokopios Magiatis; Alexios-Leandros Skaltsounis; Emmanuel Mikros; Laurent Meijer
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

6.  MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells.

Authors:  Lucy Liu; Nicolas Gaboriaud; Konstantina Vougogianopoulou; Yan Tian; Jun Wu; Wei Wen; Leandros Skaltsounis; Richard Jove
Journal:  Cancer Biol Ther       Date:  2013-11-01       Impact factor: 4.742

Review 7.  Cancer and virus leads by HTS, chemical design and SEA data mining.

Authors:  Pahk Thepchatri; Jaeki Min; Thota Ganesh; Yuhong Du; Iestyn Lewis; Serdar Kurtkaya; Andrew Prussia; Lian Li; Blossom Sneed; Richard K Plemper; Haian Fu; Dennis C Liotta; James P Snyder; Raymond Dingledine; Aiming Sun
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

Review 8.  Isatin and its derivatives: a survey of recent syntheses, reactions, and applications.

Authors:  Rita Kakkar
Journal:  Medchemcomm       Date:  2019-01-15       Impact factor: 3.597

9.  A Radioactive-free Kinase Inhibitor Discovery Assay Against the Trypanosoma brucei Glycogen Synthase Kinase-3 short (TbGSK-3s).

Authors:  Antonia Efstathiou; Despina Smirlis
Journal:  Bio Protoc       Date:  2020-01-20

10.  A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signaling.

Authors:  Lucy Liu; Marina Kritsanida; Prokopios Magiatis; Nicolas Gaboriaud; Yan Wang; Jun Wu; Ralf Buettner; Fan Yang; Sangkil Nam; Leandros Skaltsounis; Richard Jove
Journal:  Cancer Biol Ther       Date:  2012-08-16       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.